Early-Phase Drug Development in Rare Cancers: A Decade of Progress and Future Directions
- DOI
- 10.3390/cancers18203290
- Published
- 2026-10-12
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18203290,
title = {Early-Phase Drug Development in Rare Cancers: A Decade of Progress and Future Directions},
author = {Yin Mon Myat and Kyaw Zin Thein and Lujain Mahmood and Wen Wee Ma and Cathy Eng and Mohamed Shanshal},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18203290},
url = {https://doi.org/10.3390/cancers18203290}
}RIS
TY - JOUR TI - Early-Phase Drug Development in Rare Cancers: A Decade of Progress and Future Directions AU - Yin Mon Myat AU - Kyaw Zin Thein AU - Lujain Mahmood AU - Wen Wee Ma AU - Cathy Eng AU - Mohamed Shanshal PY - 2026 JO - Cancers DO - 10.3390/cancers18203290 UR - https://doi.org/10.3390/cancers18203290 ER -
APA
Myat, Y. M., Thein, K. Z., Mahmood, L., Ma, W. W., Eng, C., & Shanshal, M. (2026). Early-Phase Drug Development in Rare Cancers: A Decade of Progress and Future Directions. Cancers. https://doi.org/10.3390/cancers18203290
Source records
- crossref · retrieved 2026-11-04T17:20:43.855Z